Why the study?
Does rivaroxaban reduce symptomatic VTE compared to enoxaparin in patients after total hip or knee arthroplasty?
Does rivaroxaban reduce symptomatic VTE compared to enoxaparin in patients after total hip or knee arthroplasty?
Rivaroxaban is more effective than enoxaparin for preventing symptomatic DVT after hip or knee arthroplasty, but it increases the risk of major bleeding.
Answers are grounded in this paper and cite their sources.
Supports rivaroxaban over enoxaparin for post-arthroplasty VTE prevention with bleeding caution; confirms RCT efficacy in meta-analysis.
Venous thromboembolism (VTE) is the most widespread severe complication after total hip arthroplasty (THA) and total knee arthroplasty (TKA). We conducted this meta-analysis to further validate the benefits and harms of rivaroxaban use for thromboprophylaxis after THA or TKA. We thoroughly searched PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Trial sequential analysis (TSA) was applied to test the robustness of our findings and to obtain a more conservative estimation. Of 316 articles screened, nine studies were included. Compared with enoxaparin, rivaroxaban significantly reduced symptomatic VTE (P = 0.0001) and symptomatic deep vein thrombosis (DVT; P = 0.0001) but not symptomatic pulmonary embolism (P = 0.57). Furthermore, rivaroxaban was not associated with an increase in all-cause mortality, clinically relevant non-major bleeding and postoperative wound infection. However, the findings were accompanied by an increase in major bleeding (P = 0.02). The TSA demonstrated that the cumulative z-curve crossed the traditional boundary but not the trial sequential monitoring boundary and did not reach the required information size for major bleeding. Rivaroxaban was more beneficial than enoxaparin for preventing symptomatic DVT but increased the risk of major bleeding. According to the TSA results, more evidence is needed to verify the risk of major bleeding with rivaroxaban.
No takes yet. Share an insight, caveat, or question.
Ning et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: